img
DETERMINATION OF PROTEINS SPECIFICATION WITH SARS- COVID-19 BASED LIGAND DESIGNING    
Yazarlar
S. A. R. A. SHAHRIARI
M. A. J. I. D. MONAJJEMI
Dr. Öğr. Üyesi Fatemeh MOLLAAMIN
Kastamonu Üniversitesi
Özet
Towards to recognize a strong inhibitor we accomplished docking studies on the major virus protease with 4 natural product species as anti Covid-19(SARS-CoV-2), namely "Vidarabine", "Cytarabine", "Gemcitabine" and "Matrine" from which are extractive from Gillan's leaves plants. These are known as Chuchaq, Trshvash, Cote-Couto and Khlvash in Iran. Among these four studied compounds, Cytarabine appear as suitable compound with high effectiveness inhibitors to this protease. With docking simulation and NMR investigation we demonstrated, these compounds exhibit a suitable binding energy around 9 Kcal/mol with various ligand proteins modes in the binding to COVID-19 viruses. However, these data need further in both, vivo & vitro evaluation for repurposing these drugs against COVID-19 viruses.
Anahtar Kelimeler
Covid-19 | Gillan's leaves plants, ACE2 or Angiotensin Converting Enzyme-2 | PD or protease domain | RBD or Receptor binding domain
Makale Türü Özgün Makale
Makale Alt Türü SCOPUS dergilerinde yayımlanan tam makale
Dergi Adı Journal of the Chilean Chemical Society
Dergi ISSN 0717-9324
Dergi Tarandığı Indeksler SCOPUS
Makale Dili İngilizce
Basım Tarihi 06-2022
Cilt No 67
Sayı 2
Sayfalar 5468 / 5476
Doi Numarası 10.4067/S0717-97072022000205468